9 biosensors, microelectronics, optical, electrical, and robotic components to develop lead compounds for therapeutic development, including solid state 3-dimensional chemical synthesis matrices with semiconductor memory or encoded or engraved identifiers, such as barcodes, for characterizing molecules during discreet synthetic and assay steps by electromagnetic or optical encoding